⇀ Investment Team
Founding Partner (Paris)
Pierre is an experienced healthcare manager and deal maker.
He is the former CEO of Urgo and the former CEO of Fournier Pharma. He transformed Urgo into a global wound care giant, increasing revenue from €30m to €700m through a mix of innovation and accretive M&A. He scaled Fournier’s commercial capabilities in the United States and sold the business to Solvay for €1.3bn (excluding earnouts). Pierre began his career as a finance instructor and healthcare merchant banker at Paribas.
He is Chairman Emeritus of the Industry Association MedTech in France and is a graduate of HEC Paris.
Founding Partner (Paris)
Samuel is a physician entrepreneur.
He started his career as a management consultant at McKinsey & Company in New York before moving to Boston to attend Harvard Medical School. As a second-year medical student, Samuel co-founded Allurion Technologies and built a fully-integrated, global medical device company from the idea stage to commercialization in more than 30 countries.
Samuel is a graduate of Yale College (summa cum laude) and Harvard Medical School. He was a Fulbright Scholar to France at the Pasteur Institute.
Founding Partner (San Francisco)
Alex is a healthcare specialist investor.
After starting his career as a management consultant at McKinsey & Company in Boston, he joined Maverick Capital’s healthcare team. Alex focused on long/short public equity and venture capital/cross-over investments, ultimately as Managing Director. Alex then joined Jackson Square Partners where he focused on high-conviction healthcare public equities and led the firm’s ESG activities.
Alex is a graduate of Harvard College (magna cum laude, Phi Beta Kappa).
Edoardo is a professional investor with more than 10 years in private equity.
He started his career at Idinvest focusing on minority equity deals and secondary transactions. Subsequently, Edoardo joined BlackFin Capital Partners where he led the execution of several deals and actively participated in portfolio management and value creation efforts. He then joined Eurazeo where he leveraged his expertise in deal origination and execution and enriched his sectorial knowledge through his involvement in several verticals (Medtech, financial services, TMT).
Edoardo graduated from ESCP, City University London and the University of Turin.
Senior Investment Advisor (Paris)
Nicolas is a decorated private equity investor with more than 30 years of experience.
He started his career doing R&D at Sanofi and research at the Pasteur Institute and Harvard University (as a Tower Fellow). Nicolas transitioned from research to the Private Equity industry holding senior positions first at Electra and then at Cinven. Over more than twenty years, Nicolas led the French team and was part of the Investment Committee and Steering Committee.
Nicolas holds an MBA from INSEAD as well as an MSc in Molecular Biology from ENS Paris.